1. Home
  2. TRIB vs ICU Comparison

TRIB vs ICU Comparison

Compare TRIB & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.74

Market Cap

18.6M

Sector

Health Care

ML Signal

HOLD

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$2.51

Market Cap

15.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRIB
ICU
Founded
1992
2018
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.6M
15.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TRIB
ICU
Price
$0.74
$2.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.4M
113.4K
Earning Date
02-14-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,409,000.00
$881,000.00
Revenue This Year
$13.51
$691.85
Revenue Next Year
$13.14
$64.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1195.59
52 Week Low
$0.48
$2.20
52 Week High
$3.44
$30.70

Technical Indicators

Market Signals
Indicator
TRIB
ICU
Relative Strength Index (RSI) 39.72 89.58
Support Level $0.73 $2.40
Resistance Level $1.75 $2.81
Average True Range (ATR) 0.12 0.09
MACD -0.03 0.28
Stochastic Oscillator 2.57 86.54

Price Performance

Historical Comparison
TRIB
ICU

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: